康芝药业获ESG评级A级

Core Viewpoint - The credit rating agency Hainan Green Development Credit Rating Co., Ltd. (referred to as "Green Rating") has released ESG proactive rating results covering 5,393 listed companies, aiming to support corporate green transformation and provide transparent references for investors and regulatory bodies [2][4]. Group 1: ESG Rating Overview - The ESG proactive rating framework includes three dimensions: Environment (E), Social (S), and Governance (G), encompassing 19 core issues and over 300 data indicators, leading to a comprehensive ESG rating score for companies [4]. - Approximately 30% of the rated companies achieved an A grade or above [4]. Group 2: Company Profile - Kangzhi Pharmaceutical - Kangzhi Pharmaceutical (300086, SZ) received an A grade for its comprehensive performance in the ESG areas [2]. - The company's mission is to "act with integrity and benefit humanity through medicine," aiming to create significant changes for human health and social development [6]. - In the environmental aspect, Kangzhi adheres to a "green production, low-carbon operation" philosophy, focusing on clean production, energy conservation, and circular economy, and has been recognized as a "Green Factory of Hainan Province" and a "Waste-Free Factory of Haikou City" by 2025 [6]. - In terms of social responsibility, Kangzhi has actively engaged in disaster relief, children's welfare, public health, and sports culture events, contributing over 10 million yuan in donations and materials through initiatives like the "Kangzhi Red Face Fund" established in partnership with the China Children and Teenagers' Fund [6]. - On the governance front, Kangzhi emphasizes "compliance management and proactive governance," continuously improving its board structure, investor relations, and shareholder rights to achieve a balance between economic and social benefits [7]. - The A grade rating reflects the recognition of Kangzhi's sustainable development achievements and its commitment to high-quality development in the children's health industry [7].